Factors influencing delay in initiating antiretroviral therapy among HIV infected patients coinfected with tuberculosis

Thorax

Volumn 63, Issue 10, 2008, Pages 935-936

  Chilton, D ^a   Edwards, S G ^a   Pellegrino, P ^a   Miller, R F ^b,c  

^a Camden Primary Care Trust   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; PRIORITY JOURNAL; TUBERCULOSIS;

EID: 53649110453     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2008.104232     Document Type: Letter

References (5)

1. Schhfer JT, Sterling TR. Timing of antiretroviral therapy initiation in tuberculosis patients with AIDS. J Acquir Immune Defic Syndr 2007;44:229-34.
2. Lawn SD, Wood R. Optimum time to initiate ART in patients with HIV associated tuberculosis: there may be more than one answer. J Acquir Immune Defic Syndr 2007;46:121-3.
3. Pozniak AL, Miller RF, Lipman MC, et al. BHIVA treatment guidelines for tuberculosis (TB)/HIV infection 2005. Hiv Med 2005;6:62-83.
4. Dean GL, Edwards SG, Ives NJ. et al. Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy. AIDS 2002;16:75-83.
5. Lawn SD, Myer L. Bekker LG, et al. Tuberculosisassociated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa. AIDS 2007;21:335-41.